In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1859 News Items found
Pharmacist and herbalist Simon Yeung
Ask the Expert
How do I know if a dietary supplement contains what the label says it contains?

Pharmacist and herbalist Simon Yeung gives consumers tips on how to determine whether an herb or dietary supplement contains what’s indicated on the label.
Pictured: Jedd Wolchok & Alexander Rudensky
Announcement
Memorial Sloan Kettering Shares Historic Gift to Fund Immunotherapy Research

Immunologist Alexander Rudensky and medical oncologist and immunologist Jedd Wolchok are investigating innovative ways to use the immune system to fight cancer.
Pictured: Stem cell-derived nerve cells exposed to progerin
In the Lab
Researchers Fast-Forward Stem Cell Aging to Study Degenerative Diseases

A team of Memorial Sloan Kettering scientists has come up with an approach to make stem-cell-derived neurons rapidly age in a cell culture dish. The breakthrough could transform research into Parkinson’s and other late-onset diseases.
Cancer research pioneer Janet Rowley
In Memoriam
Memorial Sloan Kettering Mourns the Death of Cancer Research Pioneer Janet Rowley

Memorial Sloan Kettering President and CEO Craig Thompson reflects on the life and career of cancer research pioneer Janet Rowley.
Pictured: Alexander Rudensky
Profile
At Work: Immunologist Alexander Rudensky

Alexander Rudensky’s research focuses on the role of a subset of white blood cells called regulatory T cells, which are believed to suppress the immune system’s ability to fight tumors.
Pictured: Charles L. Sawyers, William Polkinghorn & Simon Powell
In the Lab
Molecular Studies Explain Effectiveness of Longtime Treatment for Prostate Cancer

Laboratory studies have revealed an explanation for why androgen-deprivation therapy makes radiation therapy more effective in the treatment of high-risk prostate cancer.
In the News
New Biotech Startup Will Pit the Immune System Against Cancer

Memorial Sloan Kettering’s partnership in a pioneering effort to speed the development of cancer immunotherapies drew national headlines.
Pictured: Michael Foley
Announcement
Michael Foley Named Director of Tri-Institutional Therapeutics Discovery Institute

A renowned chemist with 25 years of industry and academic experience, Michael Foley will lead a pioneering collaboration designed to speed the development of new drugs for people with cancer and other diseases.
Pictured: Azeez Farooki
Ask the Expert
How does having diabetes affect my cancer treatment?

Memorial Sloan Kettering endocrinologist Azeez Farooki discusses the risk factors associated with diabetes and why cancer treatment may be more complicated for those who are diabetic.
Pictured: Joan Massagué
Announcement
Cancer Biologist Joan Massagué Named Director of the Sloan Kettering Institute

Internationally recognized cancer biologist Joan Massagué has been named Director of the Sloan Kettering Institute. He was previously Chair of the Cancer Biology and Genetics Program at Memorial Sloan Kettering.